4//SEC Filing
Dorton Stephen M 4
Accession 0001104659-22-072531
CIK 0001868912other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 9:40 PM ET
Size
7.3 KB
Accession
0001104659-22-072531
Insider Transaction Report
Form 4
Enfusion, Inc.ENFN
Dorton Stephen M
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-06-15+16,000→ 16,000 totalExercise: $9.86Exp: 2032-06-15→ Class A Common Stock (16,000 underlying) - Award
Class A Common Stock
2022-06-15+10,142→ 186,613 total
Footnotes (2)
- [F1]Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The restricted stock units will vest in full as follows: 3,381, 3,381 and 3,380 restricted stock units will vest on June 15, 2023, June 15, 2024 and June 15, 2025, respectively.
- [F2]These options were granted under the Plan and shall become exercisable as follows: 5,334, 5,333 and 5,333 on June 15, 2023, June 15, 2024 and June 15, 2025, respectively.
Documents
Issuer
Enfusion, Inc.
CIK 0001868912
Entity typeother
Related Parties
1- filerCIK 0001884480
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 9:40 PM ET
- Size
- 7.3 KB